Ironwood Pharmaceuticals stock heads toward November 9 results
Published on 10/17/2026 at 18:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResults date and valuation
- Financhill lists November 9, 2026 as Ironwood Pharmaceuticals' next earnings date.
- Ironwood traded 2,530,652 shares on October 16, 2026.
- Ironwood Pharmaceuticals stock was USD 3.50 at 4:00 p.m. ET on October 16, 2026, down 7.16 percent from USD 3.77.
- Market capitalization was USD 578.3 million on October 16, 2026.
Financhill lists November 9, 2026 as Ironwood Pharmaceuticals' next earnings date. The scheduled report gives investors the next fixed point after a sharp Nasdaq decline. Ironwood Pharmaceuticals stock was last at USD 3.50 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, down 7.16 percent from USD 3.77.
Valuation at USD 578.3 million
Ironwood's market capitalization stood at USD 578.3 million on October 16, 2026. The price-to-earnings ratio was 4.56, while the company does not pay a dividend according to the same market snapshot. The valuation is tied to a business built around gastrointestinal therapies, led by LINZESS and supported by development programs such as apraglutide, according to Ironwood Pharmaceuticals.
Price position on Nasdaq
The stock's 52-week range was USD 1.44 to USD 5.78 on October 16, 2026. At USD 3.50, the price stood 39.45 percent below the high and 143.06 percent above the low. Trading volume reached 2,530,652 shares, versus an average of 1,993,879 shares, putting the session volume 26.90 percent above its average.
Ironwood's second-quarter 2026 results included USD 113.04 million in revenue and USD 51.29 million in GAAP net income. Those figures were published in the company's quarterly results release dated October 9, 2026, which also described updated full-year guidance, according to Ironwood Pharmaceuticals.
Comparison with peers
IRWD: minus 7.16 percent, P/E 4.56, market capitalization USD 578.3 million
AbbVie (NYSE, USD): plus 0.71 percent, P/E 80.42, market capitalization USD 504.4 billion
Takeda Pharmaceutical (NYSE, USD): plus 1.13 percent, P/E 55.47, market capitalization USD 62.6 billion
Next date for the stock
The November 9, 2026 reporting date is the next scheduled company event identified for Ironwood. The price picture remains tied to Nasdaq trading: the stock was USD 3.50 at 4:00 p.m. ET on October 16, 2026, while the 52-week high was USD 5.78.
Ironwood Pharmaceuticals stock facts
- Company: Ironwood Pharmaceuticals, Inc.
- ISIN: US46333X1081
- Ticker: IRWD
- Primary exchange: Nasdaq
- Price Nasdaq (as of October 16, 2026, 4:00 p.m. ET): USD 3.50
- Change versus Nasdaq previous close: minus 7.16 percent
- Previous close: USD 3.77
- Market capitalization: USD 578.3 million (as of October 16, 2026)
- 52-week range: USD 1.44-5.78 (as of October 16, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
- Next earnings date: November 9, 2026
Market context: Market report Nasdaq Composite.
